ISRCTN ISRCTN67230654
DOI https://doi.org/10.1186/ISRCTN67230654
Secondary identifying numbers 1.1
Submission date
04/05/2013
Registration date
06/06/2013
Last edited
01/09/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Damage to joint surface in the knee is commonly caused by sports injuries and falls. It does not restore itself when injured and ultimately the patient may develop arthritis in the knee joint. Many techniques have been developed to repair the damaged surface and the most commonly performed technique (gold standard) is micro fracture. In this procedure, drill holes are made in the damaged cartilage via a keyhole surgery (arthroscopy) to promote bleeding and scar tissue in place of the damaged surface. This technique has variable results and does not lead to the formation of new joint surface. Much research has been done on the ability of stems cells (patient’s own biological cells) to change into new joint surface cells. This study aims to find out the effectiveness of a new surgical procedure (ABICUS - Autologous Bone marrow Implantation of Cells University of Southampton), involving the use of patient’s own stem cells to restore joint surface in the knee and compare the results of this surgery with an existing, well established technique.

Who can participate?
Patients aged 18 to 65 with a proven joint defect in the knee

What does the study involve?
Patients are randomly allocated to one of two groups. Group 1 receive the conventional treatment (microfracture) and group 2 receive ABICUS. In group 2 patients, following anaesthesia, a sample of cells from inside the bone (bone marrow sample) is taken from the hip using a fine needle. A keyhole surgery of the knee is then performed and a mixture of the cells from the sample is collected and fibrin glue (an adhesive) is placed over the damaged area and allowed to set. Outcome scores using questionnaires and MRI scans of the knee are compared in the two groups.

What are the possible benefits and risks of participating?
There will be no risks different to those involved in the conventional treatment.

Where is the study run from?
University Hospital Southampton NHS Foundation Trust (UK)

When is the study starting and how long is it expected to run for?
July 2013 to July 2015

Who is funding the study?
Neurotechnics Ltd (UK)

Who is the main contact?
Mr Gorav Datta
gdatta@doctors.org.uk

Study website

Contact information

Mr Gorav Datta
Scientific

Southampton General Hospital
Tremona Road
Southampton
SO16 6YD
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleAutologous Bone Marrow Implantation University of Southampton (ABICUS) versus Microfracture in the knee
Study acronymABICUS
Study objectivesABICUS has a better clinical outcome than microfracture in the knee.
Ethics approval(s)Not available at the time of registration
Health condition(s) or problem(s) studiedMusculoskeletal surgery
Intervention1. Group 1: microfracture
2. Group 2: ABICUS (Autologous Bone Marrow Implantation University of Southampton) procedure
Intervention typeProcedure/Surgery
Primary outcome measureClinical function, measured by the mean Lysholm, Knee injury and Osteoarthritis Outcome Score (KOOS) and International Knee Documentation Committee (IKDC) scoring scales at 6 weeks, 3 months, 6 months, 1 and 2 years post-operatively
Secondary outcome measuresCartilage growth, assessed by MRI [Magnetic resonance Observation of CArtilage Repair Tissue (MOCART) score] at 1 and 2 years post-operatively
Overall study start date01/07/2013
Completion date01/07/2015

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants40
Key inclusion criteria1. Participant is willing and able to give informed consent for participation in the study
2. Male or female, aged 18 years to 65 years
3. Diagnosed with articular cartilage defect in the knee as assessed on MRI scan
4. No other significant medical comorbidities (medical diseases)
5. Able and willing to comply with all study requirements
Key exclusion criteria1. Generalised and/or inflammatory arthritis
2. Active joint inflammation
3. Obvious deformity in the knee
4. Age below 18 and over 65 years
5. Significant medical comorbidities
Date of first enrolment01/07/2013
Date of final enrolment01/07/2015

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Southampton General Hospital
Southampton
SO16 6YD
United Kingdom

Sponsor information

Neurotechnics Limited (UK)
Industry

c/o Gary Swattridge
Cephalon House
Unit 8 Manor Park
Banbury
Banbury
OX16 3TB
United Kingdom

ROR logo "ROR" https://ror.org/03hmb2468

Funders

Funder type

Industry

Neurotechnics Limited (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

01/09/2020: No publications found. Added trial website.
09/08/2017: No publications found, verifying study status with principal investigator.